Skip to content
lifestyle.cleanweb.co
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Alzheimer’s Drug Discovery Foundation
FDA Clearance of C2N Diagnostics’ PrecivityAD2 Blood Test Advances Precision Medicine for Alzheimer’s, Building on Groundwork Laid by Early ADDF Investment
August 20, 2026
The ADDF Highlights Encouraging Progress Toward Targeting Multiple Alzheimer’s Pathologies in Biogen’s Phase 2 Tau Study
May 14, 2026
Goodes Prize Recipient Dr. Jeff Cummings’ 2026 Alzheimer’s Drug Pipeline Report Signals New Era of Biology-Driven Approaches
May 5, 2026